GEMINA LABORATORIES LTD.

0.3439+0.11 (+48.9%)

Oct 29, 4:00:00 PM EDT · OTC Markets OTCPK · GLABF · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

26.33M

P/E (TTM)

Basic EPS (TTM)

-0.04

Dividend Yield

About

Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.

CEO

Mr. Brian Firth

IPO

3/29/2022

Website

https://www.geminalabs.com

Sector

Healthcare

Industry

Biotechnology